Standout Papers

Intensive blood-glucose control with sulphonylureas or insulin compared wi... 1991 2026 2002 2014 7.0k
  1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. (1998)
    R. C. Turner, Charles Fox et al. The Lancet
  2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) (1994)
    Anders Olsson, John J.V. McMurray et al. The Lancet
  3. Breast cancer (2019)
    Nadia Harbeck, Frédérique Penault‐Llorca et al. Nature Reviews Disease Primers
  4. Breast cancer (2016)
    Nadia Harbeck, Michael Gnant The Lancet
  5. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. (1991)
    Jean Sneddon, J. W. Densem et al. PubMed
  6. Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial (2005)
    R. Jakesz, W. Jonat et al. The Lancet
  7. Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen (2009)
    Mitch Dowsett, Jack Cuzick et al. Journal of Clinical Oncology
  8. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019 (2019)
    Harold J. Burstein, Giuseppe Curigliano et al. Annals of Oncology
  9. Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2 (2014)
    Martine Piccart, Gabriel N. Hortobágyi et al. Annals of Oncology
  10. Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis (2013)
    Denise A. Yardley, Shinzaburo Noguchi et al. Advances in Therapy

Immediate Impact

11 by Nobel laureates 4 from Science/Nature 138 standout
Sub-graph 1 of 16

Citing Papers

Deciphering breast cancer: from biology to the clinic
2023 Standout
Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer
2023 Standout
18 intermediate papers

Works of Michael Gnant being referenced

St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer
2021
Lumpectomy Plus Tamoxifen or Anastrozole With or Without Whole Breast Irradiation in Women With Favorable Early Breast Cancer
2007
and 12 more

Author Peers

Author Last Decade Papers Cites
Michael Gnant 12748 9756 5477 8679 550 37.0k
Hashem B. El‐Serag 10006 8366 10301 22584 641 67.1k
John A. Baron 12083 3679 5285 9449 516 38.8k
Patrick Maisonneuve 16762 10045 7026 11821 555 40.6k
Elisabeth G.E. de Vries 23721 6262 7229 5145 1.0k 46.9k
Scott M. Lippman 12512 7757 10375 4741 520 36.3k
Gregory J. Gores 13911 9015 11065 23083 583 61.8k
Charles L. Loprinzi 15069 2289 5002 3273 523 32.2k
Børge G. Nordestgaard 3412 8578 8545 26288 936 63.7k
Charles S. Fuchs 29385 8595 9264 8888 720 57.4k
Douglas B. Evans 22740 6940 7966 12760 493 36.0k

All Works

Loading papers...

Rankless by CCL
2026